Notably, administration of a DPP4 inhibitor resulted in higher concentrations of the chemokines CCL11, interleukin (IL)-4, IL-5, and IL-33 in tumor extracts and increased migration of eosinophils into solid tumors. Here, IL33 is linked to neoplasm.